Skip to main content
Clinical Trials/ACTRN12611000984998
ACTRN12611000984998
Completed
未知

In patients undergoing hip arthroscopy, how would platelet rich plasma, compared with placebo, improve post operative outcome in the short and long term.

Dr. Omer Mei-Dan0 sites105 target enrollmentSeptember 15, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
The study Will include patients who elect to go through a surgical procedure in order to treat a pre existing hip injury such as FAI (Femoral acetabular impingement).
Sponsor
Dr. Omer Mei-Dan
Enrollment
105
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 15, 2011
End Date
June 21, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr. Omer Mei-Dan

Eligibility Criteria

Inclusion Criteria

  • 1\. healthy patients undergoing hip Arthroscopy due to FAI
  • 2\. Ages 16\-50
  • 3\. No OA changes according to XR and surgery observation
  • 4\. No previous hip surgery
  • 5\. No other influential disabilities in lower limbs 6\. No chronic use of NSAID, steroids or chemotherapy drugs

Exclusion Criteria

  • Non\-ambulating patients, those with severe advanced osteoarthritic changes on radiological imaging, patients with suspected previous joint infection, pregnant or lactating women, open wounds or skin ulcers and those taking anticoagulants or having a prolonged bleeding time were excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials